Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans
NCT ID: NCT03037216
Last Updated: 2020-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2016-12-15
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Exercise of Secreted Factors From Muscle and Adipose Tissue
NCT02565823
Exercise Regulation of Human Adipose Tissue
NCT03133156
Myokine Identification Following Acute Exercise
NCT06223035
Effects of a Single Bout of Exercise on Transcriptomics and Metabolomics in Adipose Tissue
NCT04865965
Effect of Exercise on Metabolic Health
NCT02001142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Exercise-Training Intervention
Subjects will undergo a 10-week aerobic exercise protocol.
Exercise Intervention
10 Week aerobic exercise training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Intervention
10 Week aerobic exercise training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* HbA1c ≥ 5.7%; heart or lung disease
* acute systemic infection accompanied by fever, body aches, or swollen lymph glands
* BMI \> 27 kg/m2
* current dieting or weight loss efforts
* current pregnancy or breastfeeding
* known history of HIV/AIDS; cancer
* biochemical evidence of renal or hepatic dysfunction; renal or liver disease demyelinating diseases such as multiple sclerosis or amyotrophic lateral sclerosis
* recent blood donation
* clinical history of stroke
* hypertension (systolic \> 140 mmHg or diastolic \> 90 mmHg)
* type 1 or 2 diabetes; inability to exercise at 50% of predicted heart rate (HR) reserve at baseline
* Participants taking beta-blockers Participants who screen positive for The American Heart Association's contraindications to exercise testing
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Daiichi Sankyo
INDUSTRY
Joslin Diabetes Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurie J Goodyear, PhD
Role: PRINCIPAL_INVESTIGATOR
Joslin Diabetes Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Joslin Diabetes Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-34
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.